← Leaderboards
Ajay Nmn Rana
Jesse Brown Va Medical Center
$4,853,289
Attributed
$6,231,569
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $867.4K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,231,569 · 3
VA$0 · 5
By mechanism
R01$6,231,569 · 3
I01$0 · 4
IK6$0 · 1
Top collaborators
- Song Li5 shared
Most similar at Jesse Brown Va Medical Center
Same institution · by research overlap
- Basabi Rana$2,081,612
Others in their field
Top investigators on “Phosphotransferases”
- David Heimbrook · Leidos Biomedical Research, Inc.$26,594,235
- Gary L. Johnson · National Jewish Health$21,727,284
- Peter Karl Sorger · Massachusetts Institute Of Technology$20,231,592
- Lewis C Cantley · Beth Israel Deaconess Medical Center$19,866,259
- Richard L Huganir · Johns Hopkins University$18,390,405
- Fulton T Crews · University Of North Carolina Chapel Hill$17,915,277
Research focus
PhosphotransferasesPathway InteractionsMalignant NeoplasmsAnimal ModelCell DeathCellsMediatingReportingClinical TrialsFamilySignal TransductionInhibitor/AntagonistBaseFuturePlayTumorCeramidesCell SurvivalMalignant Breast NeoplasmLaboratoriesPhysiologicalPathogenesisCell LineOverexpression
Grant awards (42)
BLR&D Research Career Scientist Award Application$0
IK6 · FY2025 · VA · contact PI
Rational Combination of MAP4K4 Inhibition and Immunotherapy in Pancreatic Cancer$0
I01 · FY2024 · VA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2024 · VA · contact PI
Rational Combination of MAP4K4 Inhibition and Immunotherapy in Pancreatic Cancer$0
I01 · FY2023 · VA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2023 · VA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2022 · VA · contact PI
Rational Combination of MAP4K4 Inhibition and Immunotherapy in Pancreatic Cancer$0
I01 · FY2022 · VA · contact PI
Developing Nano Technology for HER2 Directed Therapy$428,652
R01 · FY2021 · CA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2021 · VA · contact PI
Rational Combination of MAP4K4 Inhibition and Immunotherapy in Pancreatic Cancer$0
I01 · FY2021 · VA · contact PI
Developing Nano Technology for HER2 Directed Therapy$680,572
R01 · FY2020 · CA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2020 · VA · contact PI
Developing Nano Technology for HER2 Directed Therapy$678,715
R01 · FY2019 · CA · contact PI
Targeting Mixed Lineage Kinase3-Hedgehog Axis in Pancreatic Cancer$0
I01 · FY2019 · VA · contact PI
Developing Nano Technology for HER2 Directed Therapy$463,483
R01 · FY2018 · CA · contact PI
Targeting Mixed Lineage Kinase3-Hedgehog Axis in Pancreatic Cancer$0
I01 · FY2018 · VA · contact PI
Developing Nano Technology for HER2 Directed Therapy$505,138
R01 · FY2017 · CA · contact PI
Oncogenic MLK3-Pak1 Signaling in ER Negative Breast Cancer$362,242
R01 · FY2017 · CA · contact PI
Targeting Mixed Lineage Kinase3-Hedgehog Axis in Pancreatic Cancer$0
I01 · FY2017 · VA · contact PI
Role of Sprouty 2 in Hepatocellular Carcinoma$0
I01 · FY2017 · VA · contact PI
Oncogenic MLK3-Pak1 Signaling in ER Negative Breast Cancer$362,185
R01 · FY2016 · CA · contact PI
Targeting Mixed Lineage Kinase3-Hedgehog Axis in Pancreatic Cancer$0
I01 · FY2016 · VA · contact PI
Role of Sprouty 2 in Hepatocellular Carcinoma$0
I01 · FY2016 · VA · contact PI
Oncogenic MLK3-Pak1 Signaling in ER Negative Breast Cancer$298,903
R01 · FY2015 · CA · contact PI
Targeting Mixed Lineage Kinase3-Hedgehog Axis in Pancreatic Cancer$0
I01 · FY2015 · VA · contact PI
Oncogenic MLK3-Pak1 Signaling in ER Negative Breast Cancer$289,936
R01 · FY2014 · CA · contact PI
Oncogenic MLK3-Pak1 Signaling in ER Negative Breast Cancer$311,744
R01 · FY2013 · CA · contact PI
Regulation of Breast Cancer Growth by MLK-3$0
I01 · FY2013 · VA · contact PI
Regulation of Breast Cancer Growth by MLK-3$0
I01 · FY2012 · VA · contact PI
Regulation of Breast Cancer Growth by MLK-3$0
I01 · FY2011 · VA · contact PI
Regulation of Breast Cancer Growth by MLK-3$0
I01 · FY2011 · VA · contact PI
Role of Mixed Lineage Kinase 3/SPRK in Stress Signaling$268,374
R01 · FY2010 · GM · contact PI
Role of Mixed Lineage Kinase 3/SPRK in Stress Signaling$88,610
R01 · FY2010 · GM · contact PI
Role of Mixed Lineage Kinase 3/SPRK in Stress Signaling$246,101
R01 · FY2009 · GM · contact PI
Role of Mixed Lineage Kinase 3/SPRK in Stress Signaling$271,084
R01 · FY2008 · GM · contact PI
Role of Mixed Lineage Kinase 3/SPRK in Stress Signaling$50,000
R01 · FY2008 · GM · contact PI
Role of Mixed Lineage Kinase 3/SPRK in Stress Signaling$236,880
R01 · FY2006 · GM · contact PI
MIXED LINEAGE KINASE, SPRK IN STRESS SIGNALING$176,295
R01 · FY2003 · GM
MIXED LINEAGE KINASE, SPRK IN STRESS SIGNALING$171,203
R01 · FY2002 · GM
MIXED LINEAGE KINASE, SPRK IN STRESS SIGNALING$166,258
R01 · FY2001 · GM
MIXED LINEAGE KINASE, SPRK IN STRESS SIGNALING$103,216
R01 · FY2000 · GM
MIXED LINEAGE KINASE, SPRK IN STRESS SIGNALING$71,978
R01 · FY2000 · GM